Answers are grounded in this paper and cite their sources.
These findings from a retrospective cohort of plaque radiotherapy and prophylactic intravitreal bevacizumab in patients with uveal melanoma suggest better visual outcomes when compared with nonrandomized historical control individuals through 4 years.
No takes yet. Share an insight, caveat, or question.
Shields et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: